Impact of SARS-CoV-2 variants on inpatient clinical outcome.

Matthew L RobinsonC Paul MorrisJoshua F BetzYifan ZhangRobert BollingerNatalie WangDavid R ThiemannAmary FallRaghda E EldesoukiJulie M NortonDavid C GastonMichael FormanChun Huai LuoScott L ZegerAmita GuptaBrian T GaribaldiHeba H Mostafa

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Although risk of severe disease or death for unvaccinated inpatients with Omicron was lower than Delta, it was similar to ancestral lineages. Severe outcomes were less common in vaccinated inpatients, with no difference between Delta and Omicron infections.

Keyphrases

sars cov
early onset
palliative care
mental health
copy number
respiratory syndrome coronavirus
drug induced
gene expression
type diabetes
adipose tissue
coronavirus disease